These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol. Extermann P; Bischof P; Marguerat P; Mermillod B Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261 [TBL] [Abstract][Full Text] [Related]
6. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies. Benn PA Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476 [TBL] [Abstract][Full Text] [Related]
7. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening. Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898 [TBL] [Abstract][Full Text] [Related]
8. Serum markers for Down's syndrome in relation to number of previous births and maternal age. Wald NJ; Watt HC Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278 [TBL] [Abstract][Full Text] [Related]
10. [Significance of the maternal levels of serum alpha-fetoprotein, human chorionic gonadotropin and unconjugated estriol in various congenital developmental defects in pregnancy trimester II]. Kostiuk EV; Zolotukhina TV; Kuznetsov MI Genetika; 1992 Sep; 28(9):158-62. PubMed ID: 1282117 [TBL] [Abstract][Full Text] [Related]
11. Effect of allowing for ethnic group in prenatal screening for Down's syndrome. Watt HC; Wald NJ; Smith D; Kennard A; Densem J Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277 [TBL] [Abstract][Full Text] [Related]
12. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome. Wald NJ; Cuckle HS; Densem JW; Stone RB Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176 [TBL] [Abstract][Full Text] [Related]
13. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome. Cuckle HS; Holding S; Jones R; Groome NP; Wallace EM Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244 [TBL] [Abstract][Full Text] [Related]
14. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong. Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604 [TBL] [Abstract][Full Text] [Related]
15. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization. McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771 [TBL] [Abstract][Full Text] [Related]
16. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Wald NJ; Cuckle HS; Densem JW; Kennard A; Smith D Br J Obstet Gynaecol; 1992 Feb; 99(2):144-9. PubMed ID: 1372820 [TBL] [Abstract][Full Text] [Related]
17. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction. Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282 [TBL] [Abstract][Full Text] [Related]
18. The prediction of adverse pregnancy outcome using low unconjugated estriol in the second trimester of pregnancy without risk of Down's syndrome. Kim SY; Kim SK; Lee JS; Kim IK; Lee K Yonsei Med J; 2000 Apr; 41(2):226-9. PubMed ID: 10817024 [TBL] [Abstract][Full Text] [Related]
19. Prenatal screening for Down's syndrome with use of maternal serum markers. Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344 [TBL] [Abstract][Full Text] [Related]